Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain

about

Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain

Item

http://www.wikidata.org/entity/Q58761563

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Cannabinoids and spinal cord s ...... rgery syndrome refractory pain

@en

Cannabinoids and spinal cord s ...... rgery syndrome refractory pain

@nl

type

Item

label

Cannabinoids and spinal cord s ...... rgery syndrome refractory pain

@en

Cannabinoids and spinal cord s ...... rgery syndrome refractory pain

@nl

prefLabel

Cannabinoids and spinal cord s ...... rgery syndrome refractory pain

@en

Cannabinoids and spinal cord s ...... rgery syndrome refractory pain

@nl

P1476

Cannabinoids and spinal cord s ...... rgery syndrome refractory pain

@en

P2093

Alessia A Barbagallo

http://www.w3.org/2001/XMLSchema#string

Carmen Mannucci

http://www.w3.org/2001/XMLSchema#string

Cristina Mondello

http://www.w3.org/2001/XMLSchema#string

Domenico Quattrone

http://www.w3.org/2001/XMLSchema#string

Epifanio Mondello

http://www.w3.org/2001/XMLSchema#string

Giuseppe Bova

http://www.w3.org/2001/XMLSchema#string

Martina Di Pietro

http://www.w3.org/2001/XMLSchema#string

Raffaella Mallamace

http://www.w3.org/2001/XMLSchema#string

P2860

The Epidemiology of Chronic Pain of Predominantly Neuropathic Origin. Results From a General Population Survey

Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities

Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials

The orphan receptor GPR55 is a novel cannabinoid receptor

Failed back surgery syndrome: current perspectives

Etiologies of failed back surgery syndrome

Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors

Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review

Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide

Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement

P304

1761-1767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/JPR.S166617

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gioacchino Calapai

Vincenzo Arcoraci

Luigi Cardia

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30233233

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoids

P932

6134407

http://www.w3.org/2001/XMLSchema#string